| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |